17β-Estradiol and soy phytochemicals selectively induce a type 2 polarization in mesenteric lymph nodes of ovariectomized rats

Menopause

Volumn 15, Issue 4, 2008, Pages 718-725

  Gallo, Daniela ^a   Battaglia, Alessandra ^a   Mantuano, Elisabetta ^a   Travaglia, Daniele ^a   Stefano, Ilaria De ^a   Buzzonetti, Alexia ^a   Scambia, Giovanni ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b University of Sacred Heart   (Italy)

Author keywords

Estrogens; Immune system; Menopause; Phytoestrogens; Rat; TH1 T H2

Indexed keywords

ESTRADIOL; GAMMA INTERFERON; IMMUNOGLOBULIN CLASS; INTERLEUKIN 4; PHYTOESTROGEN; SOYSELECT; UNCLASSIFIED DRUG; ESTROGEN; IMMUNOGLOBULIN; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; FEMALE; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE SUBPOPULATION; MENOPAUSE; MESENTERY LYMPH NODE; NONHUMAN; OVARIECTOMY; POLARIZATION; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SOYBEAN; TH1 CELL; TH2 CELL; ANIMAL; BLOOD; DRUG EFFECT; IMMUNOLOGY; LYMPH NODE; MESENTERY; SPRAGUE DAWLEY RAT;

ANIMALS; ESTRADIOL; ESTROGENS; FEMALE; IMMUNOGLOBULINS; LYMPH NODES; LYMPHOCYTE SUBSETS; MESENTERY; OVARIECTOMY; PHYTOESTROGENS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS;

EID: 51449111879     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318167b92a     Document Type: Article

References (36)

1. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001;2:777-780.
2. World Health Organization. Women, Ageing and Health (fact sheet no. 252). Geneva: World Health Organization, 2000.
3. Yang JH, Chen CD, Wu MY, Chao KH, Yang YS, Ho HN. Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-F production in postmenopausal women. Fertil Steril 2000;74:261-267.
4. Kamada M, Irahara M, Maegawa M, et al. B cell subsets in postmeno- pausal women and the effect of hormone replacement therapy. Maturitas 2001;37:173-179.
5. Deguchi K, Kamada M, Irahara M, et al. Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause 2001;8:266-273.
6. Kamada M, Irahara M, Maegawa M, et al. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol 2001;184:309-314.
7. Porter VR, Greendale GA, Schocken M, Zhu X, Effros RB. Immune effects of hormone replacement therapy in post-menopausal women. Exp Gerontol 2001;36:311-326.
8. Stopinska-Gluszak U, Waligora J, Grzela T, et al. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mono-nuclear cells of postmenopausal women. J Reprod Immunol 2006;69:65-75.
9. Benassayag C, Perrot-Applanat M, Ferre F. Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci 2002;777:233-248.
10. Cassidy A, Albertazzi P, Lise Nielsen I, et al. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 2006;65:76-92.
11. Cooke PS, Selvaraj V, Yellayi S. Genistein, estrogen receptors, and the acquired immune response. J Nutr 2006;136:704-708.
12. Gallo D, Zannoni GF, Apollonio P, et al. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectom-ized rat model of menopause: effects on bone, uterus, and lipid profile. Menopause 2005;12:589-600.
13. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342:1209-1210.
14. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoes-trogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 2002;132:3168-3171.
15. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7:105-111.
16. Maecker HT, Rinfret A, D'Souza P, et al. Standardization of cytokine flow cytometry assays. BMC Immunol 2005;6:13.
17. 2 cytokine production. Curr Drug Targets Inflamm Allergy 2004;3:97-104.
18. Mosmann TR, Sad S. The expanding universe of T cell subsets - Th1, Th2 and more. Immunol Today 1996;17:138-146.
19. Croft M, Carter L, Swain SL, Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of inter-leukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1994;180:1715-1728.
20. + T cells secreting TH1 or TH2 cytokines. Immunity 1995;2:271-279.
21. Romagnani S. TH1 and TH2 in human diseases. Clin Immunol Immunopathol 1996;80:225-235.
22. Kumru S, Godekmerdan A, Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J Reprod Immunol 2004;63:31-38.
23. Attanasio R, Gust DA, Wilson ME, Meeker T, Gordon TP. Immuno-modulatory effects of estrogen and progesterone replacement in a nonhuman primate model. J Clin Immunol 2002;22:263-269.
24. Yilmazer M, Fenkci V, Fenkci S, Aktepe O, Sonmezer M, Kurtay G. Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy postmenopausal women. Hum Reprod 2003;18:1531-1535.
25. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 2006;83:1118-1125.
26. Yellayi S, Zakroczymski MA, Selvaraj V, et al. The phytoestrogen genistein suppresses cell-mediated immunity in mice. J Endocrinol 2003;176:267-274.
27. O'Connor TP, Liesen DA, Mann PC, Rolando L, Banz WJ. A high isoflavone soy protein diet and intravenous genistein delay rejection of rat cardiac allografts. J Nutr 2002;132:2283-2287.
28. Lang TJ. Estrogen as an immunomodulator. Clin Immunol 2004;113:224-230.
29. Carlsten H. Immune responses and bone loss: the estrogen connection. Immunol Rev 2005;208:194-206.
30. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors αand β. Endocrinology 1997;138:863-870.
31. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142:953-962.
32. Gompel A, Piette JC. Systemic lupus erythematosus and hormone replacement therapy. Menopause Int 2007;13:65-70.
33. Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann N Y Acad Sci 1999;876:131-143.
34. D'Elia HF, Mattsson LA, Ohlsson C, Nordborg E, Carlsten H. Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. Arthritis Res Ther 2003;5:R202-R209.
35. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-3584.
36. Setchell KD, Clerici C, Lephart ED, et al. S-equol, a potent ligand for estrogen receptor A, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 2005;81:1072-1079.